These findings demonstrate that baicalin mitigates GPS-induced peritonitis by suppressing the ADAM17/EGFR axis and the subsequent cytokine production, thus providing a theoretical basis for novel GPS control strategies and the development of novel non-antibiotic strategies, including phytochemical therapeutics and feed additives. The gene discussed is ADAM17; the disease is peritonitis.